Live Breaking News & Updates on Sensorion

Stay updated with breaking news from Sensorion. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Sensorion Submits Clinical Trial Application for OTOF-GT, its Lead Gene Therapy Candidate, in Europe

MONTPELLIER, France, July 19, 2023 Sensorion Submits Clinical Trial Application for OTOF-GT, its Lead Gene Therapy Candidate, in Europe ....

United Kingdom , France General , Cruz Tapia , Stuart Isabelle Abdou , Nawal Ouzren , Institut Pasteur , Pierre Louis Germain , Eu Community Register , Communications Europe France , Consilium Strategic Communications , European Medicines Agency , Regulatory Agency , Drug Administration , International Media Relations , Regulatory News , Clinical Trial Application , Drug Product , Orphan Drug Designation , Rare Pediatric Disease Designation , Chief Executive Officer , Chief Medical Officer , Cisplatin Induced Ototoxicity , Cochlear Limited , Sudden Sensorineural Hearing Loss , Del Castillo , Drug Designations ,

Sensorion Will Present Two Posters At The American Society Of Cell And Gene Therapy (ASGCT) 26th Annual Meeting

Regulatory News: Sensorion (FR0012596468 ALSEN) a pioneering clinical-stage biotechnology company which specializes in gene therapies in the ear, is pleased to announce its participation in the ....

United States , Los Angeles , David Lawrence , Institut Pasteur , Matthew Cole Jessica Hodgson , Head Of Preclinical Development , Vector Development Platform For Inner Ear Disorders , Preclinical Development , Communications Europe France , International Media Relations , Strategic Communications , Regulatory News , Chief Medical Officer , Annual Meeting , Inner Ear , Wednesday May , Adeno Associated Vector Based Gene Therapy , Autosomal Recessive Non Syndromic Deafness , Thursday May , Cisplatin Induced Ototoxicity , Cochlear Limited , Sudden Sensorineural Hearing Loss , Chief Financial Officer , United Kingdom , Investor Relations , Sue Stuart ,

Sensorion : Terms of availability of the preparatory documents for the GM

Press release

Sensorion provides preliminary documents for the Combined

shareholders General Meeting of May 24, 2023

. | May 3, 2023 ....

France General , Institut Pasteur , Square Louvois , General Meeting , Combined General Meeting , French Commercial Code , Annual General Meeting , Combined Shareholder General Meeting , Sensorion Stock Exchange , Press Release , Ay Alsen Fr0012596468 ,

Sensorion Provides Preliminary Documents for the Combined Shareholders' General Meeting of May 24, 2023

Regulatory News: Sensorion (FR0012596468 ALSEN) a pioneering clinical-stage biotechnology company which specializes in gene therapies in the inner ear, announces that the Company's shareholders ....

France General , David Lawrence , Square Louvois , Institut Pasteur , Communications Europe France , Consilium Strategic Communications , International Media Relations , Regulatory News , Combined General Meeting , French Commercial Code , General Meeting , Annual General Meeting , Combined Shareholder General Meeting , Cisplatin Induced Ototoxicity , Cochlear Limited , Sudden Sensorineural Hearing Loss , Chief Financial Officer , United Kingdom , Investor Relations , Strategic Communications , Sue Stuart ,

Sensorion Announces the Publication of Its 2022 Annual Financial Report

30.03.2023 - Regulatory News: Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in gene therapies in the inner ear, announces that its Annual Financial Report for the year ending December 31, 2022, is available . ....

Lang Schwarz , Professeur Joseph Blayac , Institut Pasteur , Company Headquarters , Management Report , Annual Accounts , Financial Statements , Annual Financial Report , Financial Information , Cochlear Limited , Sudden Sensorineural , Hearing Loss , Sensorion Stock ,